The Future of Oncology Summit is the first-ever statewide event co-hosted by Yale Cancer Center and BioCT. This two-day convening brings together leading voices in oncology from across the nation for forward-looking insights, high-impact networking, and strategic collaboration shaping the next era of cancer innovation.

The Summit is organized around three key areas of focus:

Annie Lamont
Managing Partner, Oak HC/FT

Cliff Hudis, MD
CEO, ASCO

David Scheer, MS
President, Scheer & Company;
BioCT Co-Chair

Eric Winer, MD, FASCO
Director, Yale Cancer Center;
President and Physician-in-Chief,
Smilow Cancer Hospital

Kat Kayser-Bricker, PhD
CSO, Halda Therapeutics

Ranjit Bindra, MD, PhD
Professor of Therapeutic Radiology,
Yale School of Medicine

Kathy Lynch
Oncology Nurse Educator,
Gilead Sciences

Janie Merkel, PhD
Corporate Strategy Officer,
Yale University

Yale Cancer Center is one of a select group of National Cancer Institute (NCI)-designated comprehensive cancer centers in the United States. For more than 50 years, it has united leading scientists and physicians from Yale School of Medicine and Smilow Cancer Hospital to advance innovative cancer research and patient care. Its mission is to reduce the burden of cancer in Connecticut and beyond through transformative science, community partnership, and equitable access to exceptional care.

BioCT is the life sciences trade organization for the state of Connecticut. The not-for-profit organization serves as the voice of more than 300 member companies. Its mission is to catalyze and accelerate growth in the life sciences with the goal of improving human health, by fostering a rich, innovative ecosystem, and promoting Connecticut as a preferred destination for life sciences exploration and innovation.